WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 Issue has been successfully launched on 1 OCTOBER 2024.

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

INCIDENCE OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS IN NINEVEH PROVINCE

*Dr. Ahmed Saadoon Hassoon, Dr. Omar Riyadh Abdulla, Dr. Shatha Yousif Sheet, Dr. Aymen Tareq Ibrahim, Dr. Israa Jawdat Mustafa, Dr. Ahmed Sabah Mohammed Jamil, Dr. Hasan Ayad Hazim, Dr. Mustafa Yaser Al-Tamr and Dr. Asmaa Mahmood Omar

ABSTRACT

Background: Cancer patients are at an increased risk of developing venous thromboembolism (VTE). VTEincreases morbidity and mortality rates in cancer patients and differs by primary cancer type, stage of cancer, andtype of Treatment. The reported incidence rate of VTE varies widely between studies due to differences inascertainment and the underlying populations represented. This study aimed to find the VTE incidence rate andthe related risk factors in Nineveh. Methods: A prospective cohort study was used to determine the incidence rate of VTE in cancer patients. Data was gathered between January 2022 and January 2023, and patients werefollowed for twelve months after cancer diagnosis. Results: A total of 1968 patients were eligible for analysis.The most common cancer type was breast cancer. Forty-six patients had VTE, and the 12-month cumulative ofVTE was 2.3%. Smoking, distant metastasis, and receiving systemic chemotherapy were the most significantfactors in developing VTE. One-third of patients with VTE had metastasis in comparison with 20% in the wholecohort. However, age and tumor types had no significant difference in risk for developing VTE in cancer patients. Conclusion: In Nineveh, breast cancer was the most frequent tumor found among the studied groups. The overallincidence of VTE was consistent with that reported in other studies in different countries. The risk of developing VTE in patients with cancers was influenced by receiving systemic chemotherapy and the stage of cancer. Smoking also increases the risk of VTE in the cancer population.

[Full Text Article] [Download Certificate]